| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net sales | $12.3M-15.0% | $14.5M-41.5% | $24.7M+3.8% | $23.8M-49.7% | $47.4M+11.0% | $42.7M |
| Cost of goods sold | $5.7M-26.5% | $7.8M-43.4% | $13.7M+12.1% | $12.2M-57.0% | $28.4M+28.2% | $22.1M |
| Gross profit | $6.6M-1.8% | $6.7M-39.2% | $11.1M-5.0% | $11.6M-38.8% | $19.0M-7.5% | $20.6M |
| Sales and marketing | $5.8M+15.6% | $5.0M-61.9% | $13.1M-26.7% | $17.9M-5.2% | $18.8M+7.2% | $17.6M |
| General and administrative | $15.1M-16.6% | $18.1M+28.1% | $14.1M-12.1% | $16.1M+17.3% | $13.7M+28.6% | $10.6M |
| Research and development | $4.2M+38.9% | $3.0M-31.8% | $4.4M-43.1% | $7.7M-16.6% | $9.3M+55.6% | $6.0M |
| Litigation costs, net | $8.5M-25.2% | $11.4M+13.8% | $10.0M+92.1% | $5.2M+1784.1% | $276K | — |
| Total operating expenses | $33.5M-10.5% | $37.4M-10.0% | $41.6M-11.2% | $46.8M+11.4% | $42.1M+23.1% | $34.2M |
| Loss from continuing operations | -$26.9M+12.4% | -$30.7M-0.6% | -$30.5M+13.3% | -$35.2M-52.8% | -$23.0M-69.4% | -$13.6M |
| Interest (income) expense, net | $387K+141.4% | -$934K | — | — | — | — |
| (Gain) loss on revaluation of warrant liability | -$13.4M-190.2% | $14.9M+259.4% | $4.1M | — | — | — |
| Other expense (income), net | $2.8M+332.5% | -$1.2M-256.3% | $759K+118.2% | -$4.2M-16.2% | -$3.6M-239.4% | $2.6M |
| Loss from continuing operations before provision for income taxes | -$15.9M+65.0% | -$45.3M-10.0% | -$41.2M-14.0% | -$36.1M-45.9% | -$24.8M-13.7% | -$21.8M |
| Income tax expense | $13K+85.7% | $7K-75.0% | $28K-17.6% | $34K-38.2% | $55K+111.5% | $26K |
| Net loss from continuing operations | -$15.9M+65.0% | -$45.3M-9.9% | -$41.2M-14.0% | -$36.2M | — | — |
| (Income) loss from discontinued operations | $69.3M+904.9% | -$8.6M-339.5% | $3.6M+9.4% | $3.3M | — | — |
| Net income (loss) | $53.4M+198.9% | -$53.9M-43.3% | -$37.7M-14.5% | -$32.9M-32.5% | -$24.8M-13.8% | -$21.8M |
| Less: dilutive gain on revaluation of warrant liability | -$13.4M | — | — | — | — | — |
| Net income (loss) for dilutive earnings per share | $39956000.00+174.1% | -$53949000.00 | — | — | — | — |
| Net loss from continuing operations per share - basic (in dollars per share) | -$380.00+75.6% | -$1560.00+31.3% | -$2270.00+13.4% | -$2620.00 | — | — |
| Net loss from continuing operations per share - diluted (in dollars per share) | -$640.00+59.0% | -$1560.00+31.3% | -$2270.00+13.4% | -$2620.00 | — | — |
| Net income (loss) from discontinued operations per share - basic (in dollars per share) | $1670.00+656.7% | -$300.00-250.0% | $200.00-16.7% | $240.00 | — | — |
| Net income (loss) from discontinued operations per share - diluted (In dollars per share) | $1510.00+603.3% | -$300.00-250.0% | $200.00-16.7% | $240.00 | — | — |
| Net income (loss) per share - basic (in dollar per share) | $1290.00+169.4% | -$1860.00+10.1% | -$2070.00+13.0% | -$2380.00+0.0% | -$2380.00+73.2% | -$8880.00 |
| Net income (loss) per share - diluted (in dollar per share) | $870.00+146.8% | -$1860.00+10.1% | -$2070.00+13.0% | -$2380.00+0.0% | -$2380.00+73.2% | -$8880.00 |
| Weighted average common shares outstanding - basic (in shares) | 41.42B+42.5% | 29.07B+60.1% | 18.16B+31.3% | 13.83B+32.4% | 10.44B+266.2% | 2.85B |
| Weighted average common shares outstanding - diluted (in shares) | 45.94B+58.0% | 29.07B+60.1% | 18.16B+31.3% | 13.83B+32.4% | 10.44B+266.2% | 2.85B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.